3rd Quarter - Report

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

H.R. 9495/S Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT)

LobbyistCovered position, as disclosed
MARK VIETH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9495 (119th)

Health Issues HCR

H.R. 9495/S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); H.R. 9260/S. Unnumbered, FY 2027 Labor-HHS-Education Act, Funding for National HHT Center of Excellence Program

LobbyistCovered position, as disclosed
MARK VIETH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9260 (119th), H.R. 9495 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.